You are here

  • Home
  • Archive
  • Volume 8, Issue 9
  • Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)

Article metrics

Article menu

Download PDFPDF

XML
Neurology
Protocol
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)

 

Online download statistics by month:

Online download statistics by month: September 2018 to June 2025

AbstractFullPdf
Sep 201831030627
Oct 20181601577
Nov 20181281279
Dec 20181461463
Jan 201960596
Feb 201951506
Mar 2019343415
Apr 2019201711
May 2019302831
Jun 201935327
Jul 2019292912
Aug 201917175
Oct 2019121212
Nov 201924259
Dec 2019201915
Jan 2020151514
Feb 202015155
Mar 2020313110
May 2020222221
Jun 2020191826
Jul 2020171625
Aug 2020282816
Sep 2020262614
Oct 2020242415
Nov 2020161513
Dec 202016168
Jan 2021272521
Feb 2021171717
Mar 2021404030
Apr 202114157
May 202110108
Jun 2021222212
Jul 2021323114
Aug 2021262639
Sep 2021393835
Oct 2021302936
Nov 2021252433
Dec 2021414121
Jan 2022272913
Feb 2022242420
Mar 2022464724
Apr 2022565420
May 2022292824
Jun 2022302921
Jul 2022575725
Aug 202229287
Sep 2022222117
Oct 2022252410
Nov 2022191812
Dec 202213126
Jan 202326268
Feb 2023211911
Mar 202321204
Apr 2023171510
May 202326259
Jun 202326273
Jul 202314147
Aug 202323248
Sep 202318184
Oct 202317163
Nov 2023121413
Dec 202318185
Jan 202416163
Feb 2024151110
Mar 202418146
Apr 2024202014
May 202416147
Jun 2024121011
Jul 2024271510
Aug 20241185
Sep 202420195
Oct 202411104
Nov 2024212111
Dec 2024895
Jan 2025424223
Feb 202567642
Mar 2025333118
Apr 2025323212
May 2025191917
Jun 2025221
Total263425661063